Research first to combine targeted agents to kill multiple myeloma cells

(PhysOrg.com) -- Scientists at Virginia Commonwealth University Massey Cancer Center have developed a novel treatment strategy for multiple myeloma that pairs two targeted agents to kill cancer cells. The study’s findings, published in today’s edition of the journal “Blood,” are the first to demonstrate the synergistic, anti-myeloma effects of this combination regimen both in vitro and in vivo.

Read the whole article on Physorg

More from Physorg